Search

Your search keyword '"Nadir Askenasy"' showing total 131 results

Search Constraints

Start Over You searched for: Author "Nadir Askenasy" Remove constraint Author: "Nadir Askenasy"
131 results on '"Nadir Askenasy"'

Search Results

1. Two Distinct Mechanisms Mediate the Involvement of Bone Marrow Cells in Islet Remodeling: Neogenesis of Insulin-Producing Cells and Support of Islet Recovery

2. Critical early events in hematopoietic cell seeding and engraftment.

3. Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice.

4. Apoptosis of purified CD4+ T cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice.

5. Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease

7. Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege

8. Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation

9. Restless Leg Syndrome in Neurologic and Medical Disorders

10. Less Is More: The Detrimental Consequences of Immunosuppressive Therapy in the Treatment of Type-1 Diabetes

11. Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes

12. Physiological functions of TNF family receptor/ligand interactions in hematopoiesis and transplantation

13. Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts

14. Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cells

15. Surge in regulatory cells does not prevent onset of hyperglycemia in NOD mice

16. Killer Treg cells ameliorate inflammatory insulitis in non-obese diabetic mice through local and systemic immunomodulation

17. Early immunisation with dendritic cells after allogeneic bone marrow transplantation elicits graft vs tumour reactivity

18. Depletion of Naïve Lymphocytes with Fas Ligand Ex Vivo Prevents Graft-versus-Host Disease without Impairing T Cell Support of Engraftment or Graft-versus-Tumor Activity

19. TNF-α Has Tropic Rather than Apoptotic Activity in Human Hematopoietic Progenitors: Involvement of TNF Receptor-1 and Caspase-8

20. Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes

21. Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective

22. Primitive Stem Cells Derived from Bone Marrow Express Glial and Neuronal Markers and Support Revascularization in Injured Retina Exposed to Ischemic and Mechanical Damage

23. IL-2–Targeted Therapy Ameliorates the Severity of Graft-versus-Host Disease: Ex Vivo Selective Depletion of Host-Reactive T Cells and In Vivo Therapy

24. Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation

25. Pancreatic Islets Engineered with SA-FasL Protein Establish Robust Localized Tolerance by Inducing Regulatory T Cells in Mice

26. Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation

27. Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumors

28. Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice

29. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis

30. A Fusion Protein Composed of IL-2 and Caspase-3 Ameliorates the Outcome of Experimental Inflammatory Colitis

31. Graft versus neuroblastoma reaction is efficiently elicited by allogeneic bone marrow transplantation through cytolytic activity in the absence of GVHD

32. Apoptosis as a mechanism of T‐regulatory cell homeostasis and suppression

33. Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycle

34. Induction of Tolerance to Cardiac Allografts Using Donor Splenocytes Engineered to Display on Their Surface an Exogenous Fas Ligand Protein

35. Mechanisms of T regulatory cell function

36. Participation of Adult Bone Marrow-Derived Stem Cells in Pancreatic Regeneration: Neogenesis Versus Endogenesis

37. Fas Ligand Enhances Hematopoietic Cell Engraftment Through Abrogation of Alloimmune Responses and Nonimmunogenic Interactions

38. Pancreatic Islets Under Attack: Cellular and Molecular Effectors

39. Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?

40. Bone Marrow Homing Enriches Stem Cells Responsible for Neogenesis of Insulin-Producing Cells, While Radiation Decreases Homing Efficiency

41. Towards Possible Cure of Cancer by Immunotherapy of Minimal Residual Disease

42. The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation

43. Our Perception of Developmental Plasticity Esse Est Percipi (to be is to be Perceived)?

44. ProtExTM: A Novel Technology to Display Exogenous Proteins on the Cell Surface for Immunomodulation

45. Immunomodulation with regulatory T cells and Fas-ligand ameliorate established inflammatory colitis

46. The topologic and chronologic patterns of hematopoietic cell seeding in host femoral bone marrow after transplantation

47. In vivo imaging studies of the effect of recipient conditioning, donor cell phenotype and antigen disparity on homing of haematopoietic cells to the bone marrow

48. Cell Membrane Modification for Rapid Display of Proteins as a Novel Means of Immunomodulation

49. Optical Imaging of PKH‐Labeled Hematopoietic Cells in Recipient Bone Marrow In Vivo

50. Transplanted Hematopoietic Cells Seed in Clusters in Recipient Bone Marrow In Vivo

Catalog

Books, media, physical & digital resources